At a glance
- Originator Takeda
- Class Antihypertensives; Ischaemic heart disorder therapies
- Mechanism of Action Potassium channel agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Angina pectoris; Hypertension